About Clear Labs
The Problem Clear Labs addresses a core biotech pain point: fragmented operations, slow decision cycles, and poor visibility across teams. Organizations in this market often rely on disconnected tools, which creates delays, revenue leakage, and inconsistent customer outcomes.
The Solution Clear Labs is a provider of a fully-automated sequencing platform for turnkey diagnostics. Biotech Healthcare Robotics Hardware In practice, Clear Labs centralizes critical workflows, automates repetitive coordination, and gives operators a real-time system of record. This reduces manual overhead and improves execution quality at scale.
Why it's growing With the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Clear Labs is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Culture The team operates in a fast-paced environment focused on biotech innovation, product velocity, and customer-centric execution. Their culture emphasizes ownership, experimentation, and measurable outcomes.
Why it Matters
Clear Labs matters now because with the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Clear Labs is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Funding Snapshot
- Series C • Khosla Ventures, $58M Series C in 2020
Hiring Roles
This company is actively hiring.
Meet the Founders
Clear Labs Team
Founder & CEO

